The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Change in T2-weighted signal intensity, change in tumor volume, and exposure-response analysis in the RINGSIDE phase 2 study of varegacestat in patients with desmoid tumors.
 
Mrinal Gounder
Honoraria - Gerson Lehrman Group; Great Debates and Updates; Guidepoint Global; Med Learning Group; Medscape; MJH/PER; OncLive/MJH Life Sciences; Research to Practice
Consulting or Advisory Role - AADi; Ayala Pharmaceuticals; Epizyme; Ikena Oncology; Kura Oncology; Rain Therapeutics
Research Funding - AADi (Inst); Athenex (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Erasca, Inc (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Ikena Oncology (Inst); Kymera (Inst); Rain Oncology (Inst); Regeneron (Inst); SERVIER (Inst); SpringWorks Therapeutics (Inst); Tango Therapeutics (Inst); Vivace Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - GODDESS PRO Desmoid Tumor (Inst); UpToDate
Travel, Accommodations, Expenses - Epizyme
Other Relationship - Desmoid Tumor Research Foundation
(OPTIONAL) Uncompensated Relationships - Foundation Medicine
 
Bernd Kasper
Honoraria - Bayer; GlaxoSmithKline; Pharmamar-zeltia
Consulting or Advisory Role - Ayala Pharmaceuticals; Bayer; Boehringer Ingelheim; GlaxoSmithKline; SpringWorks Therapeutics
Research Funding - Ayala Pharmaceuticals (Inst); Cogent Medicine (Inst); Immunome (Inst); PharmaMar (Inst); SpringWorks Therapeutics (Inst)
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; InhibRx; Recordati; SpringWorks Therapeutics
Research Funding - Adaptimmune; Astex Pharmaceuticals (Inst); Ayala Pharmaceuticals (Inst); Cogent Biosciences (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Kronos Bio (Inst); Pfizer (Inst); PharmaMar (Inst); Polaris (Inst); PTC Therapeutics (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Expert Testimony - Reminger Co, LPA
 
Arun Singh
Leadership - Certis Oncology Solutions
Stock and Other Ownership Interests - Certis Oncology Solutions
Honoraria - Galvanize Therapeutics
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Ipsen; Lilly
Speakers' Bureau - AADi; Daiichi Sankyo; Deciphera; Eisai; Lilly; MJH Life Sciences; Novartis; RAIN Therapeutics (Inst); Scripps Health; SpringWorks Therapeutics; TRACON Pharma (Inst)
Research Funding - Ayala Pharmaceuticals (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); deciphera (Inst); Intensity Therapeutics (Inst); Lilly (Inst); Nanocarrier (Inst); Polaris (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; Eisai; Galvanize Therapeutics; Lilly; Novartis
Other Relationship - Certis Oncology Solutions
 
Brian Van Tine
Leadership - Polaris
Honoraria - Beijing Biostar Pharmaceuticals Co., Ltd.; Oncology Education; Total Health Conference
Consulting or Advisory Role - Aadi; Acuta Capital Partners, LLC; Adaptimmune; Advenchen Laboratories; Boxer Capital LLC; Crisper Therapeutics; Daiihi Sankyo; Deciphera; Galapagos NV; Hinge Bio; Kronos Bio, Inc.; Putnam Associates; Salarius Pharmaceuticals, INc.; Syneos Health
Research Funding - Polaris
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; Kronos Bio, Inc
 
Vladimir Andelkovic
Stock and Other Ownership Interests - Moleculin Biotech
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Eisai
Research Funding - Ayala Pharmaceuticals (Inst); BMS (Inst); Boehringer Ingelheim (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis
 
Janet Yoon
No Relationships to Disclose
 
Edwin Choy
Consulting or Advisory Role - Adaptimmune; Bayer; Daiichi Sankyo; Epizyme
Research Funding - Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim; Exelixis (Inst); Genentech/Roche; Immune Design (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); TRACON Pharma (Inst)
 
Jeremy Lewin
No Relationships to Disclose
 
Javier Martin Broto
Leadership - Sarcoma Research Solutions SL
Consulting or Advisory Role - Amgen; Asofarma; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Roche; Tecnofarma
Speakers' Bureau - PharmaMar
Research Funding - Adaptimmune; Amgen (Inst); Arog (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); CEBIOTEX (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai; Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Nektar (Inst); Novartis; Novartis (Inst); Pfizer (Inst); PharmaMar; PharmaMar (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Ravin Ratan
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Medtronic (I)
Honoraria - Peerview; touchIME
Consulting or Advisory Role - InhibRx; SpringWorks Therapeutics
Research Funding - Ayala Pharmaceuticals (Inst); C4 Therapeutics (Inst); SpringWorks Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - SpringWorks Therapeutics; SpringWorks Therapeutics
 
Nam Bui
Consulting or Advisory Role - AADi; Boehringer Ingelheim; Checkpoint Capital; EcoR1 Capital; Immunome; Rain Therapeutics; SpringWorks Therapeutics
Research Funding - SpringWorks Therapeutics
 
Winette Van Der Graaf
Consulting or Advisory Role - Agenus (Inst); Bayer (I); Novartis (I); PTC Therapeutics (Inst)
Research Funding - Lilly (Inst)
 
Lara Davis
Consulting or Advisory Role - Daiichi Sankyo; InhibRx; Regeneron; SpringWorks Therapeutics
Research Funding - Adaptimmune (Inst); BioAtla (Inst); BTG (Inst); Eisai (Inst); Epizyme (Inst); Immunome (Inst); InhibRx (Inst); Intensity Therapeutics (Inst); Novartis (Inst); Salarius Pharmaceuticals (Inst); SERVIER (Inst); SpringWorks Therapeutics (Inst)
 
Atrayee Basu Mallick
Stock and Other Ownership Interests - Alexion Pharmaceuticals (I); BMS (I); Pfizer (I)
Consulting or Advisory Role - daichi sanyo; deciphera; deciphera
Research Funding - Advenchen Laboratories (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); InhibRx (Inst); Lilly (Inst); Prelude Therapeutics (Inst); Prelude Therapeutics (Inst); PTC therapeutics (Inst); Pyramid Biosciences (Inst); rgenix; Rgenix (Inst); The Academic GI Cancer Consortium (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Rgenix
 
Hyo Song Kim
No Relationships to Disclose
 
Eric Song
Employment - Immunome Inc; Neoleukin Therapeutics; ProfoundBio
Stock and Other Ownership Interests - Immunome Inc
 
Jonathan Yovell
Consulting or Advisory Role - Immunome
Travel, Accommodations, Expenses - Immunome
 
Robin Jones
Consulting or Advisory Role - Adaptimmune; Athenex; Bayer; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim; Clinigen Group; Daiichi Sankyo; Deciphera; Eisai; Epizyme; Immodulon Therapeutics; Immune Design; Immunicum; Karma Oncology; Lilly; Merck Serono; Morphotek; Mundipharma; PharmaMar; SpringWorks Therapeutics; SynOX; TRACON Pharma; UpToDate
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Gerald Fetterly
Employment - Immunome
Stock and Other Ownership Interests - Immunome
Travel, Accommodations, Expenses - Immunome